Drug Resistance Patterns and Trends in Patients with Suspected Drug-Resistant Tuberculosis in Dalian, China: A Retrospective Study-Reference-Cited by-同舟云学术

Drug Resistance Patterns and Trends in Patients with Suspected Drug-Resistant Tuberculosis in Dalian, China: A Retrospective Study

Published:2022-07 Issue: Volume:Volume 15 Page:4137-4147
ISSN:1178-6973
Container-title:Infection and Drug Resistance
language:en
Short-container-title:IDR

Author:

Pan Yuanping,Yu Yingying,Lu Jiachen,Yi Yaohui,Dou Xiaofeng,Zhou Ling

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology

Reference39 articles.

1. World Health Organization. Definitions and Reporting Framework for Tuberculosis – 2013 Revision. Geneva, Switzerland: World Health Organization; 2013.

2. Efficacy of bedaquiline in the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

3. Implementing tuberculosis preventive treatment in high-prevalence settings

4. World Health Organization. Global Tuberculosis Report 2021. Geneva, Switzerland: World Health Organization; 2021.

5. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and patterns of drug-resistant Mycobacterium tuberculosis in newly diagnosed patients in China: A systematic review and meta-analysis;Journal of Global Antimicrobial Resistance;2024-09

2. Assessing the quality of life in patients with drug-resistant tuberculosis: a cross-sectional study;BMC Pulmonary Medicine;2024-06-27

3. Factores asociados al tratamiento no exitoso para tuberculosis en pacientes previamente tratados en Cali, Colombia, en el periodo 2015-2019;Biomédica;2023-09-30

4. The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study;BMC Infectious Diseases;2023-03-15

5. Analysis of Risk Factors of Drug Resistance in Multidrug-Resistant Tuberculosis;Advances in Clinical Medicine;2023